Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Crystal clear data would spike valuation

<< Previous

Bullboard Posts

Next >>

Comment by Oden6570on Jun 15, 2022 2:06am

177 Views

Post# 34757138

RE:RE:Crystal clear data would spike valuation

Infinity wrote: Sci First Absolutely no question, When we are dealing with small samples, it is so much better to release data in absolute numbers instead of percentages that are subject to various interpretations.
I simply do not get it... why would the TLT management purposely keep the test results low key, almost get the feeling our management is trying to fly under the radar for reasons that I do not understand.

Certainly not in the shareholders best interests IMHO.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks